期刊文献+

普乐沙福的波谱学特征和结构确证 被引量:1

Spectroscopic characteristics and structure identification of plerixafor
下载PDF
导出
摘要 目的测定普乐沙福的波谱学特征,确证其化学结构。方法利用红外光谱(IR)、紫外光谱(UV)、核磁共振(NMR)、高分辨质谱(MS)、热分析和X-射线粉末衍射(XRD)等技术对普乐沙福进行结构分析。结果通过解析证实普乐沙福的结构为1,1’-[1,4-亚苯基(亚甲基)]-二-1,4,8,11-四氮杂环十四烷。结论该方法准确可行,可为普乐沙福的质量控制和结构鉴定提供依据。 Objective To determine the spectroscopic characteristics and to identify the chemical structure of plerixafor with a variety of analytic techniques.Methods The infrared spectrometry,ultraviolet-visible spectrometry,nuclear magnetic resonance,mass spectrometry,thermal analysis and X-ray powder diffraction were adopted to analyze the chemical structure of plerixafor.Results The chemical structure of plerixafor was determined to be 1,1’-[1,4-phenylenebis (methylene)]bis-1,4,8,11-tetraazacyclotetradecane.Conclusion The method is accurate and reliable,and it can provide a reference for the production control and identification of plerixafor.
作者 江任之 梁平 王玲 程红 曾甜甜 严定策 JIANG Ren-zhi;LIANG Ping;WANG Ling;CHENG Hong;ZENG Tian-tian;YAN Ding-ce(Analytical and Testing Center,Huazhong University of Science and Technology,Wuhan 430074)
出处 《中南药学》 CAS 2021年第1期50-55,共6页 Central South Pharmacy
关键词 普乐沙福 核磁共振 红外光谱 紫外光谱 高分辨质谱 X-射线粉末衍射 波谱学特征 结构确证 plerixafor NMR IR UV MS XRD spectroscopic characteristic structure identification
  • 相关文献

参考文献11

二级参考文献111

  • 1梁改玲,连莹.高效毛细管电泳法测定盐酸伐昔洛韦含量及有关物质[J].药物分析杂志,2007,27(4):599-602. 被引量:4
  • 2翁建宇,杜欣,张建军,周茂华,吴穗晶,陆泽生,林伟,黄梓伦.G-CSF对供者外周血CD34^+细胞黏附分子表达的影响[J].中国输血杂志,2007,20(2):105-107. 被引量:6
  • 3苏靖,刘瑶,郑志兵,李松.Plerixafor的合成[J].中国医药工业杂志,2007,38(6):398-400. 被引量:5
  • 4XU D Q,MATTNER P G,PRASAD K,et al. An expeditious synthesis of a biscyclam with an aromatic linker[ J]. Tetrahed- ron Lett,1996,37(30) :5301 -5304.
  • 5MICHAL A,LOLIIS S H. Direct synthesis of 1,1'-[ 1,4-phenylenebis ( methylene ) ] -bis-1,4, 8, 11 -tetraazacyclotetradecane octahydroehloride(AMD 3100) without the use of protecting groups [ J ]. J Org Chem,2003,68 ( 16 ) :6435 - 6436.
  • 6YANG W,CHRISTEN M G,MICHAEL S,et al. Facile N-1 protection of cyelam, cyclen and 1,4, 7-triazacyclononane [ J]. Tetrahedron Lett,2003,44(12) :2481 -2483.
  • 7GINA C V, GRAEME M, ELIZABETH A. ct al. Configurationally restricted bismacrocyclic CXCR4 receptor antagonists [J]. J Med Chem,2006,49(21 ) :6162 -6165.
  • 8BRIDGER G J, SKERI.J R T, VREESE K D, et al. Synthesis and structure-activity relationships of phenylenebis (methylene) linked bis tetraazamaerocyclcs that inhibit HIV replication. Effects of macrocyclic ring size and substituents on the aromatic linker[ J]. J Med Chem, 1995,38 (2) :366 -378.
  • 9Ukkipati A. Vaclavikova J. In vitro reconstitution and preparative purification of complexes between the chemokine receptor CXCR4 and its ligands SDFlalpha, gpl20-CD4 and AMD3100[ J]. Protein Expr Purif, 2006,50(2) :203- 214.
  • 10Stewart DA, Smith C. Pharmacokinetics and pharmacodynamics of plefixafor in patients with non-Hodgkin lymphoma and multiple myeloma [ J ]. Biol Blood Marrow Transplant, 2009,15 ( 1 ) : 39-46.

共引文献16

同被引文献10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部